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Abstract
Diabetic Charcot foot is characterized by varying degrees of bone and joint disorganization secondary to
underlying neuropathy, perturbations of bone metabolism and trauma. Offloading is the most important initial
treatment recommendation. Surgery can be helpful in early stages involving acute fractures of the foot or ankle
or in later stages when offloading is ineffective. Incorrect diagnosis and improper treatment often result in the
extremity having to be amputated.
There are several surgical procedures accepted in Charcot foot surgery. Their goal is to obtain a plantigrade foot
and prevent recurrent ulcerations. Arthrodesis is a well-known surgical procedure that addresses severe joint
derangement through a surgically induced bony fusion. In Charcot foot, arthrodesis is usually indicated when
there is significant skeletal instability. This procedure can be done by internal or external fixation.
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Background
Charcot’s foot affects approximately three out of
1000 diabetics, is characterized by joint dysloca-
tions, bone fractures leading to a collapse of the
bone anatomy of the foot.
There is a big dilemma in the management of
the Charcot’s foot, because of no uniformity in the
clinical and surgical care of this condition, and the
treatment is a very challenging.
We represent our experience in treatment of a
severe case.
Case presentation
We report the case of a patient aged 62 years fol-
lowed for type II diabetes evolving for 15 years,
poorly balanced (HbA1c oscillating between 9 and
10%), insulin since 2003, At the clinical exami-
nation noted a deformed right foot, swollen but
painless (Fig. 1). Moreover, there were no inflam-
matory signs. Imaging showed significant bone
destruction. Infectious, tumoral and degenerative
causes were eliminated by interrogation, clinical
examination, biological and radiological. The di-
agnosis of Charcot’s right foot was retained, it was
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arthrodesized at the beginning, 3 years ago by a
screwing but nonunion and screw migration was
noted in the evolution (Fig. 2), resumed 6 months
later by tibiotalar and subtalar arthrodesis with ret-
rograde intramedullary nail (Fig. 3).
Figure 1. Clinical image showing the Charcot
foot deformity.
The operation was carried out with the patient
in supine position under tourniquet, usually under
epidural anesthesia. Approach was on previous
lateral incision starting from about 4 cm from the
tip of the lateral malleolus and is curved anteriorly
towards the sinus tarsi, we prepared the joint surface
and removed all devitalized bone and soft tissues to
obtain excellent bone to bone contact.
We determined the entry point for the guidewire
using fluoroscopy, it is passed through the calca-
neus into the tibia, progressive reaming was done
then the nail is assembled and gently hammered
in maintaining the ankle in 5◦dorsiflexed, 5◦valgus
and slight external rotation.
The postoperative follow-up was good, patient
was discharged from the hospital at day 7, below
knee plaster cast was applied and no weight bearing
for 8 weeks. Then gradual weight bearing started.
Full weight bearing allowed after 6 months.
Evolution at 1 year is good, bone healing at
plantigrade position, no recurrent ulcerations, with
Figure 2. X-rays showing a nonunion after first
arthrodesis with screw.
Figure 3. Image after the final revision.
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resumption of walking and normal daily activities.
Discussion
Diabetic osteoarthropathy is a complication that is
manifested, at the early stage, by local inflammation
of the foot or ankle secondary to osteolysis of in-
flammatory and neuropathic origin. JM Charcot, in
1868, hypothesized that the damage was secondary
to the loss of a nutrient substance in the bone, asso-
ciated with an abnormality of vasomotor regulation
and an increase in foot circulation, the association
between the occurrence of a Charcot foot and dia-
betic neuropathy was described by WR Jordan only
in 1936 as a diabetic nerve osteoarthropathy. If, cur-
rently, the first cause of ”Charcot’s foot” is diabetes,
there are many other etiologies (tabes, rheumatoid
arthritis, multiple sclerosis, multiple myeloma, al-
coholism...) [1, 2].
The balance of diabetes and the type of diabetes
seem to play a role, with a ratio of two-thirds of type
2 diabetic patients to one-third of type 1 diabetics
[2, 3].
The difficulty of the diagnosis lies in the lack of
clinical specificity of the acute phase. It is charac-
terized by a rapid onset, even brutal, manifested by
an inflammatory aspect of the foot (edema, redness,
heat and, depending on the presence of pain).
The symptoms of the acute phase are related to
neuropathic and inflammatory disorders. The most
cited are bouncing pulses, an abolition of Achilles
osteotendinous reflexes, a decrease in tactile sensi-
tivity and sometimes articular hypermobility. The
affected foot systematically increases the tempera-
ture by 3&deg; above the contralateral foot. Gener-
ally, there is no fever and inflammatory markers are
decreased, although the latter parameter is variable.
The presence of pain is described in 75% of cases.
Its intensity is absolutely not related to the severity
of the clinical or radiological situation [4, 5].
In chronic phase the most severe deformation
is characterized by the complete dislocation of the
arch to the point of observing a collapse of the
vault. This deformity will lead to a major reduction
in joint mobility, a typical ulceration of the arch and
a foot in the form of ”tampon-blotter”.
The X-ray of the foot is the exam of choice to
confirm the clinical diagnosis. And establishes ra-
diological classifications for Charcot’s foot such as
Sanders and Frykberg classification that matches
the risk of skin lesion with the affected articular
area in Charcot’s foot. It aims to predict the risk of
ulceration by distinguishing five zones. The most
affected areas are those of the Lisfranc joint (tar-
sometatarsal joint) followed by the cuneonavicular
and talonavicular and calcaneocuboid joints [6].
MRI is the most contributory in the acute phase.
It allows visualization of medullary edema and peri-
articular inflammation, even during the ”Charcot in
situ”, which allows to start treatment more quickly.
These signs are unfortunately also present in case
of osteitis [7, 8].
Conservative treatment is the treatment of choice
in the acute phase, combining immobilization for 8
to 12 weeks and Bisphosphonates to reduce local
inflammation, but without a longer-term favorable
effect on the risk of complications, there is also
the targeted monoclonal antibody therapy targeting
RANKL such as denosumab, which is proposed for
the treatment of osteoporosis.
The failure of conservative treatment leads to
severe bone deformities, surgery is then indicated, it
consists of either an osteotomy to prevent iterative
ulcerations or arthrodesis.
Ankle arthrodesis in severe deformities due to
Charcot neuro-arthropathy joint is a good operation.
However, it is a technically challenging procedure,
because of severe deformities, previous multiple
surgeries, poor skin conditions and hight risk of
infection. The key points for arthrodesis are proper
joint preparation, compression of all the fusion ar-
eas, appropriate position of the foot and stable fix-
ation. There are multiple techniques described for
Charcot foot arthrodesis, with variable success. The
reported techniques have included the use of lock-
ing plates, screws, staples, external fixation with or
without bone transport, but with a high rate of com-
plications (infections, nonunion...). Ankle arthrode-
sis with intramedullary nail is generally reserved to
salvage the failed arthrodesis [9].
Retrograde nailing for fusion of ankle and subta-
lar joint is a successful and benefit procedure. Jehan
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S et al reviewed 33 studies, 641 patients treated with
retrograde nail. Union rate was in 86.7%. Compli-
cation rate was 55% with reoperation rate 22% [10].
Tibiotalar and subtalar arthrodesis with an IM nail
has relatively good fusion rates. However, it carries
a high risk of complications. This might be because
of the preoperative comorbidities.
Conclusions
Charcot’s neuroarthropathy is difficult to treat. Most
difficulties are deformities and joint instability. Ret-
rograde nailing for ankle and subtalar joint fusion is
a successful procedure. In comparison to old tech-
niques as plates or screws, with very poor results
including malunion, nonunion and recurrence of
deformity.
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